ATE410172T1 - Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes - Google Patents

Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes

Info

Publication number
ATE410172T1
ATE410172T1 AT02740584T AT02740584T ATE410172T1 AT E410172 T1 ATE410172 T1 AT E410172T1 AT 02740584 T AT02740584 T AT 02740584T AT 02740584 T AT02740584 T AT 02740584T AT E410172 T1 ATE410172 T1 AT E410172T1
Authority
AT
Austria
Prior art keywords
vitamin
treatment
autoimmune diabetes
analog
hexafluoro
Prior art date
Application number
AT02740584T
Other languages
English (en)
Inventor
Luciano Adorini
Nadia Giarratana
Silvia Gregori
Simona Smiroldo
Milan Uskokovic
Original Assignee
Bioxell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxell Spa filed Critical Bioxell Spa
Application granted granted Critical
Publication of ATE410172T1 publication Critical patent/ATE410172T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Steroid Compounds (AREA)
AT02740584T 2001-05-22 2002-05-10 Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes ATE410172T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01112421 2001-05-22

Publications (1)

Publication Number Publication Date
ATE410172T1 true ATE410172T1 (de) 2008-10-15

Family

ID=8177502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02740584T ATE410172T1 (de) 2001-05-22 2002-05-10 Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes

Country Status (6)

Country Link
US (1) US20040214803A1 (de)
EP (1) EP1392323B1 (de)
AT (1) ATE410172T1 (de)
AU (1) AU2002314056A1 (de)
DE (1) DE60229240D1 (de)
WO (1) WO2002094247A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307865D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
AU2004275815A1 (en) * 2003-09-24 2005-04-07 Bioxell S.P.A. 1,3-diaclyated,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
AU2005309789A1 (en) 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2alpha-methyl and 2beta-methyl analogs of 19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and their uses
NZ555283A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
ATE469127T1 (de) 2004-11-22 2010-06-15 Wisconsin Alumni Res Found 17,20(z)-dehydro-vitamin-d-analoge und deren verwendungen
US7528122B2 (en) 2006-02-02 2009-05-05 Wisconsin Alumni Research Foundation Vitamin D analog—NEL, methods and uses thereof
US7803789B2 (en) 2006-02-02 2010-09-28 Wisconsin Alumni Research Foundation Vitamin D analog—RAK, methods and uses thereof
AU2007298673A1 (en) 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof
CA2639585A1 (en) 2006-04-06 2007-10-06 Wisconsin Alumni Research Foundation 2-methylene-1.alpha., 25-dihydroxy-18, 19, 21-trinorvitamin d3 and uses thereof
JP2010505739A (ja) 2006-04-06 2010-02-25 ウイスコンシン アラムニ リサーチ ファンデーション ２−メチレン−１α，２５−ジヒドロキシ−１９，２１−ジノルビタミンＤ３類縁体およびその使用
CN103784419B (zh) * 2012-10-31 2016-03-30 成都国弘医药有限公司 一种含有骨化三醇的软胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) * 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5665387A (en) * 1994-09-01 1997-09-09 K.U. Leuven Research & Development Methods and compositions for primary and secondary prevention of autoimmune diabetes
AU4919597A (en) * 1996-10-31 1998-05-22 American Home Products Corporation Synergistic composition comprising rapamycin and calcitriol
AU1022999A (en) * 1997-09-08 1999-03-29 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs

Also Published As

Publication number Publication date
EP1392323B1 (de) 2008-10-08
US20040214803A1 (en) 2004-10-28
EP1392323A2 (de) 2004-03-03
WO2002094247A3 (en) 2003-05-01
AU2002314056A1 (en) 2002-12-03
DE60229240D1 (de) 2008-11-20
WO2002094247A2 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
DE60119784D1 (de) Cyclische salen metall verbindungen als einfänger von sauerstoffradikalen und verwendbar als antioxidantien bei der behandlung und vorbeugung von krankheiten
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
ATE510542T1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
ATE503490T1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
ATE445405T1 (de) Vorbeugung und behandlung von oxidativer-stress- erkrankungen mit verbindungen die den intrazellulären spiegel von glutathion oder phase-ii-entgiftungsenzymen erhöhen
AR043188A1 (es) Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias
DE60045427D1 (de) Bupropinmetaboliten zur Behandlung von Dementia und anderen zerebrovasckulären Erkrankungen
BR0014778A (pt) Composição antimicrobiana, processos para matar bactérias, para desativar vìrus, para aperfeiçoar a saúde global de um mamìfero, para reduzir a ausência de pessoas, utilização de composição, produto antimicrobiano e conjunto de tratamento pessoal antimicrobiano
EP0831832A4 (de) Verfahren zur bekämpfung infektiöser krankheiten unter verwendung dikationischer bis-benzimidazole
DE60229240D1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
DE60203847D1 (de) Verbindungen enthaltend S-Tofisopam sowie Verwendung dieser Verbindungen zur Herstellung eines Medikamentes zur Behandlung oder Prophylaxe von Krämpfen und Anfällen
WO2008086452A3 (en) Treatment and prevention of alzheimer's disease
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
DE602004031631D1 (de) Verwendung von betain zur behandlung von claudicatio intermittens
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE249832T1 (de) Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation
TW200608965A (en) Medicine for prevention or treatment of diabetes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties